Transfection reagent, TransIT®-BrCa

Lieferant: Mirus Bio
TransIT®
MIRUMIR5504EA 406 EUR
MIRUMIR5504 MIRUMIR5505 MIRUMIR5506 MIRUMIR5510 MIRUMIR5500
Transfection reagent, TransIT®-BrCa
Transfektionsreagenzien
TransIT®-BrCa transfection reagent offers superior DNA transfection of breast cancer cell types.

  • Achieve high expression levels in multiple breast cancer cell types
  • Formulated for low cellular toxicity – maintain cell density and reduce experimental bias
  • Superior transfection efficiency

TransIT®-BrCa transfection reagent is a dedicated breast cancer cell line specific reagent. While it delivers efficiently to many breast cancer cell types, it also maintains low cellular toxicity resulting in reduced experimental bias. TransIT®-BrCa transfection reagent exhibits higher luciferase expression in breast cancer cells compared to other transfection reagents.
Bestellen

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Mehr About VWR